Obesity: Effects on Cardiovascular Disease and its Diagnosis

References

1. ↵
   Flegal KM, Carroll MD, Ogden CL, Johnson CL. Prevalence and trends in obesity among US adults, 1999–2000. JAMA 2002; 288: 1723–7.

   OpenUrlCrossRefPubMedWeb of Science
2. Kucmarski RJ, Flegal KM, Campbell SM, Johnson CL. Increasing prevalence of overweight among US adults: The National Health and Nutrition Examination Surveys, 1960 to 1991. JAMA 1994; 272: 205–11.

   OpenUrlCrossRefPubMedWeb of Science
3. Mokdad AH, Serdula MK, Dietz WH, Bowman BA, Marks JS, Koplan JP. The spread of obesity epidemic in the United States, 1991–1998. JAMA 1999; 282: 1519–22.

   OpenUrlCrossRefPubMedWeb of Science
4. ↵
   Ogden CL, Carroll MD, McDowell MA, Flegal KM. Obesity among adults in the United States—no change since 2003–2004. NCHS data brief no 1. Hyattsville (MD): National Center for Health Statistics; 2007.
5. ↵
   Grundy SM, Brewer HB, Cleeman JI, et al. Definition of metabolic syndrome: Report of the National Heart, Lung, and Blood Institute/American Heart Association conference on scientific issues related to definition. Circulation 2004; 109: 433–8.

   OpenUrlFREE Full Text
6. ↵
   Snyder EE, Walts B, Perusse L, et al. The human obesity gene map: the 2003 update. Obes Res 2004; 12: 369–439.

   OpenUrlCrossRefPubMedWeb of Science
7. ↵
   Olshansky SJ, Passaro DJ, Hershow RC, et al. A potential decline in life expectancy in the United States in the 21st century. N Engl J Med 2005; 352: 1138–45.

   OpenUrlCrossRefPubMedWeb of Science
8. ↵
   Malik S, Wong ND, Franklin SS, et al. Impact of the metabolic syndrome on mortality from coronary heart disease, cardiovascular disease and all causes in United States adults. Circulation 2004; 110: 1245–50.

   OpenUrlAbstract/FREE Full Text
9. ↵
   Shamsuzzaman AS, Winnicki M, Lanfranchi P, et al. Elevated C-reactive protein in patients with obstructive sleep apnea. Circulation 2002; 105: 2462–4.

   OpenUrlAbstract/FREE Full Text
10. ↵
    Kern PA, Saghizadeh M, Ong JM, Bosch RJ, Deem R, Simsolo RB. The expression of tumor necrosis factor in human adipose tissue: regulation by obesity, weight loss and relationship to lipoprotein lipase. J Clin Invest 1995; 95: 2111–9.

    OpenUrlCrossRefPubMedWeb of Science
11. ↵
    Hotamisligil GS, Arner P, Caro JF, Atkinson RL, Spiegelman BM. Increased adipose tissue expression of tumor necrosis factor-alfa in human obesity and insulin resistance. J Clin Invest 1995; 95: 2409–15.

    OpenUrlCrossRefPubMedWeb of Science
12. ↵
    Lundgren CH, Brown SL, Nordt TK, Sobel BE, Fujii S. Elaboration of type-1 plasminogen activator inhibitor from adipocytes. A potential pathogenetic link between obesity and cardiovascular disease. Circulation 1996; 93: 106–10.

    OpenUrlAbstract/FREE Full Text
13. ↵
    Steppan CM, Bailey ST, Bhat S, et al. The hormone resistin links obesity to diabetes. Nature 2001; 409: 307–12.

    OpenUrlCrossRefPubMedWeb of Science
14. ↵
    Larsen OA, Lassen NA, Quaade FN. Blood flow through the human adipose tissue determined with radioactive xenon. Acta Physiol Scand 1966; 66: 337–45.

    OpenUrlPubMedWeb of Science
15. ↵
    Summers LK, Samra JS, Humphreys SM, Morris RJ, Frayn KN. Subcutaneous abdominal adipose tissue blood flow: variation within and between subjects and relationship to obesity. Clin Sci (Lond) 1996; 91: 679–83.

    OpenUrlPubMed
16. ↵
    Kaltman AJ, Goldring RM. Role of circulatory congestion in the cardiorespiratory failure of obesity. Am J Med 1976; 60: 645–53.

    OpenUrlCrossRefPubMedWeb of Science
17. ↵
    Ku CS, Lin SL, Wang DJ, Chang SK, Lee WJ. Left ventricular filling in young normotensive obese adults. Am J Cardiol 1994; 73: 613–5.

    OpenUrlCrossRefPubMedWeb of Science
18. ↵
    Collis T, Devereux RB, Roman MJ, et al. Relations of stroke volume and cardiac output to body composition: the strong heart study. Circulation 2001; 103: 820–5.

    OpenUrlAbstract/FREE Full Text
19. ↵
    De Scheerder I, Cuvelier C, Verhaaren R, De Buyzere M, De Backer G, Clement D. Restrictive cardiomyopathy caused by adipositas cordis. Eur Heart J 1987; 8: 661–3.

    OpenUrlAbstract/FREE Full Text
20. ↵
    Balsaver AM, Morales AR, Whitehouse FW. Fat infiltration of myocardium as a cause of cardiac conduction defect. Am J Cardiol 1967; 19: 261–5.

    OpenUrlCrossRefPubMed
21. ↵
    Zhou YT, Grayburn P, Karim A, et al. Lipotoxic heart disease in obese rats: implications for human obesity. Proc Natl Acad Sci USA 2000; 97: 1784–9.

    OpenUrlAbstract/FREE Full Text
22. ↵
    Poirier P, Giles TD, Bray GA, et al. Obesity and cardiovascular disease: pathophysiology, evaluation and effect of weight loss: an update of the 1997 American Heart Association Scientific Statement on Obesity and Heart Disease from the Obesity Committee of the Council on Nutrition, Physical Activity, and Metabolism. Circulation 2005; 113: 898–918.

    OpenUrlPubMed
23. ↵
    Kenchaiah S, Evans JC, Levy D, et al. Obesity and the risk of heart failure. N Engl J Med 2002; 347: 305–13.

    OpenUrlCrossRefPubMedWeb of Science
24. ↵
    Kannel WB, Plehn JF, Cupples LA. Cardiac failure and sudden cardiac death in the Framingham study. Am Heart J 1988; 115: 869–75.

    OpenUrlCrossRefPubMedWeb of Science
25. ↵
    Drenick EJ, Bale GS, Seltzer F, Johnson DG. Excessive mortality and causes of death in morbidly obese men. JAMA 1980; 243: 443–5.

    OpenUrlCrossRefPubMedWeb of Science
26. ↵
    Schouten EG, Dekker JM, Meppelink P, Kok FJ, Vandenbroucke JP, Pool J. QT interval prolongation predicts cardiovascular mortality in an apparently healthy population. Circulation 1991; 84: 1516–23.

    OpenUrlAbstract/FREE Full Text
27. ↵
    Esposito K, Nicolletti G, Marzano S, et al. Autonomic dysfunction associates with prolongation of QT intervals and blunted night BP in obese women with visceral obesity. J Endocrinol Invest 2002; 25: RC32–5.

    OpenUrlPubMed
28. ↵
    Sccareccia F, Pannozzo F, Dima F, et al. Heart rate as a predictor of mortality: the MATISS project. Am J Public Health 2001; 91: 1258–63.

    OpenUrlCrossRefPubMedWeb of Science
29. ↵
    Lalani AP, Kanna B, John J, Ferrick KJ, Huber MS, Shapiro LE. Abnormal signal averaged electrocardiogram (SAECG) in obesity. Obes Res 2000; 8: 20–8.

    OpenUrlPubMedWeb of Science
30. ↵
    Hubert HB, Feinleib M, McNamara PM, Castelli WP. Obesity as an independent risk factor for cardiovascular disease: a 26-year follow-up of participants in the Framingham Heart Study. Circulation 1983; 67: 968–77.

    OpenUrlAbstract/FREE Full Text
31. ↵
    Rabkin SW, Mathewson FA, Hsu PH. Relation of body weight to development of ischemic heart disease in a cohort of young North American men after a 26-year observation period: the Manitoba study. Am J Cardiol 1977; 39: 452–8.

    OpenUrlCrossRefPubMedWeb of Science
32. ↵
    Manson JE, Colditz GA, Stampfer MJ, et al. A prospective study of obesity and risk of coronary heart disease in women. N Engl J Med 1990; 322: 882–9.

    OpenUrlCrossRefPubMedWeb of Science
33. ↵
    McGill HC, McMahan CA, Malcom GT, Oalmann MC, Strong JP. Relation of glycohemoglobin and adiposity to atherosclerosis in youth. Pathobiological Determinants of Atherosclerosis in Youth (PDAY) Research Group. Arterioscler Thromb Vasc Biol 1995; 15: 431–40.

    OpenUrlAbstract/FREE Full Text
34. ↵
    Marik P, Varon J. The obese patient in the ICU. Chest 1998; 113: 492–8.

    OpenUrlCrossRefPubMedWeb of Science
35. ↵
    Rose DK, Cohen MM, Wigglesworth DF, DeBoer DP. Critical respiratory events in the postanesthesia care unit. Patient, surgical, and anesthetic factors. Anesthesiology 1994; 81: 410–8.

    OpenUrlCrossRefPubMedWeb of Science
36. ↵
    Brown CD, Higgins M, Donato KA, et al. Body mass index and the prevalence of hypertension and dyslipidemia. Obes Res 2000; 8: 605–19.

    OpenUrlPubMedWeb of Science
37. ↵
    Johnson AL, Cornoni JC, Cassel JC, Tyroler HA, Heyden S, Hames CG. Influence of race, sex and weight on blood pressure in young adults. Am J Cardiol 1975; 35: 523–30.

    OpenUrlCrossRefPubMedWeb of Science
38. ↵
    Partinen M, Jamieson A, Guilleminault C. Long-term outcome for obstructive sleep apnea syndrome patients. Chest 1998; 94: 1200–4.

    OpenUrl
39. ↵
    Kurth T, Gaziano JM, Berger K, et al. Body mass index and the risk of stroke in men. Arch Intern Med 2002; 162: 2557–62.

    OpenUrlCrossRefPubMedWeb of Science
40. ↵
    Rost NS, Wolf PA, Kase CS, et al. Plasma concentration of C-reactive protein and risk of ischemic stroke and transient ischemic attack: the Framingham study. Stroke 2001; 32: 2575–9.

    OpenUrlAbstract/FREE Full Text
41. ↵
    Alpert MA, Kelly DL. Value and limitations of echocardiography assessment of obese patients. Echocardiography 1986; 3: 261–72.

    OpenUrlPubMed
42. ↵
    Wong CY, O'Moore-Sullivan T, Leano R, Byrne N, Beller E, Marwick TH. Alterations of left ventricular myocardial characteristics associated with obesity. Circulation 2004; 110: 3081–7.

    OpenUrlAbstract/FREE Full Text
43. ↵
    Peterson LR, Waggoner AD, Schechtman KB, et al. Alterations in left ventricular structure and function in young healthy obese women: assessment by echocardiography and tissue Doppler imaging. J Am Coll Cardiol 2004; 43: 1399–404.

    OpenUrlCrossRefPubMedWeb of Science
44. ↵
    Alpert Ma, Terry BE, Cohen MV, Fan TM, Painter JA, Massey CV. The electrocardiogram in morbid obesity. Am J Cardiol 2000; 85: 908–10.

    OpenUrlCrossRefPubMedWeb of Science
45. ↵
    Casale PN, Devereux RB, Kligfield P, et al. Electrocardiographic detection of left ventricular hypertrophy: development and prospective validation of improved criteria. J Am Coll Cardiol 1985; 6: 572–80.

    OpenUrlPubMedWeb of Science
46. ↵
    Eisenstein EL, Shaw LK, Nelson CL, Anstrom JK, Hakim Z, Mark DB. Obesity and long-term clinical and economic outcomes in coronary artery disease patients. Obes Res 2002; 10: 83–91.

    OpenUrlPubMed